HIV-1 infection in haemophilia

Baillière's Clinical Haematology
R Madhok, C D Forbes

Abstract

Guidelines have been prepared by the National Hemophilia Foundation, USA, for treating patients with haemophilia, these are: 1. General recommendations. The risks of withholding treatment far outweigh risks of treatment. Patients should however be educated to use appropriate clotting factor doses to minimize overuse and contain costs. 2. Factor VIIIC-deficient patients. DDAVP should be used whenever possible by patients with mild or moderate factor VIIIC deficiency. When feasible, an alternative to concentrates may be the use of cryo-precipitate prepared from one well-screened donor or from a small number of such donors. (a) Prevention of hepatitis. Hepatitis B vaccination is essential for uninfected patients. Preliminary data suggest that products that are pasteurized, solvent/detergent-treated or monoclonal antibody-purified are at a reduced risk of transmitting hepatitis viruses. (b) Prevention of HIV-1. Concentrates pasteurized, treated with solvent/detergent, purified with monoclonal antibody, heated in suspension with organic solvents, or dry heat-treated for long periods are preferred. These products carry a substantially reduced risk of transmitting HIV-1. 3. Factor IX deficiency. For patients with severe deficiency the...Continue Reading

References

Aug 1, 1978·The Journal of Infectious Diseases·T ShikataT Oda
Aug 1, 1977·British Journal of Haematology·D S PepperJ D Cash
Aug 1, 1975·Journal of Clinical Pathology·P M MannucciZ M Ruggeri
Feb 1, 1989·Journal of Clinical Pathology·J G LoweC D Forbes
Jan 9, 1986·The New England Journal of Medicine·R R RedfieldE C Tramont
Jul 15, 1988·Annals of Internal Medicine·A C CollierH H Handsfield
Feb 21, 1985·The New England Journal of Medicine·B L EvattR B Ramsey
Jul 19, 1986·British Medical Journal·R Cheinsong-PopovR Weiss
Apr 1, 1988·British Journal of Haematology·P M MannucciM Colombo
Jun 2, 1988·The New England Journal of Medicine·A E GlattS H Landesman
Apr 1, 1985·British Journal of Haematology·S A Larsson
Aug 24, 1985·British Medical Journal·D Francis, R Judson
Dec 30, 1965·The New England Journal of Medicine·J G Pool, A E Shannon
Dec 6, 1984·The New England Journal of Medicine·C TsoukasM Robert-Guroff
Dec 10, 1983·British Medical Journal·M L FletcherC R Rizza
Nov 22, 1984·Nature·G A VeharD J Capon

❮ Previous
Next ❯

Citations

Apr 1, 1992·Baillière's Clinical Haematology·T WeberA F Fleming
Apr 1, 1992·Baillière's Clinical Haematology·A C Nathwani, E G Tuddenham
Dec 1, 1994·Social Science & Medicine·E Nauenberg, S D Sullivan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Haemophilia : the Official Journal of the World Federation of Hemophilia
J BatlleM F Lopez-Fernandez
Hematology/oncology Clinics of North America
J M Lusher
© 2021 Meta ULC. All rights reserved